FindTrial
Sign In

To study response to thiopurines (a drug used for treatment in Inflammatory Bowel Disease including Ulcerative colitis and Crohns Disease)

Optimized use of Thiopurines in Inflammatory Bowel Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027444
Enrollment
100
Registered
2020-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K50- Crohns disease [regional enteritis] Health Condition 2: K51- Ulcerative colitis

Interventions

None listed

Sponsors

Dayanand Medical College and Hospital Ludhiana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with Inflammatory Bowel Disease receiving thiopurines 2. Patientâ??s demonstration of understanding of study requirements and treatment procedures, willingness to comply with all protocol-required evaluations

Exclusion criteria

Exclusion criteria: 1. Pregnant/lactating female 2. History or other evidence of severe illness or any other conditions that would make the patient, in the opinion of the investigator, unsuitable for the study (such as poorly controlled psychiatric disease, HIV, significant co-morbidities like advanced coronary artery disease, etc.)

Design outcomes

Primary

MeasureTime frame
To study the factors impacting the use and response to thiopurines in patients with IBDTimepoint: 3 years 6 months—

Secondary

MeasureTime frame
To study the factors impacting the use and response to thiopurines in patients with IBDTimepoint: 3 years 6 months—

Countries

India

Contacts

Public ContactAjit Sood

Department of Gastroenterology

ajitsood10@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026